Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119208) titled 'Clinical Effectiveness and Safety of IL-1 Inhibitors Plus Urate-Lowering Therapy Compared to Conventional Treatment in Patients with Refractory Gout: A Real-World Study' on Feb. 24.
Study Type: Interventional study
Study Design:
Non randomized control
Primary Sponsor: Tianjin Medical University Chu Hsien-I Memorial Hospital
Condition:
Gout
Intervention:
IL-1 inhibitor group:Firsekibart + uric acid-lowering drugs
Traditional treatment group:Colchicine, NSAIDs , or hormones
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-24
Target Sample Size: IL-1 inhibitor group...